Tumor Suppression Activity of Ginsenoside Rg3 Combined with TRAIL Gene on Human Colon Cancer Cell Line HCE8693

何超,吴彤,胡晓彤,梁建华,陈萍

DOI: https://doi.org/10.3321/j.issn:1001-2494.2004.08.013

2004-01-01

Abstract:OBJECTIVE To find a new way to treat cancer using traditional Chinese medicine and modem gene therapy.The effects of ginsenoside Rg3 and ginsenoside Rg3 combined with TRAIL gene on human colon cancer cell line HCE8693 were evaluated.METHODS Human colon cancer cell line HCE8693 was transfected with adenovirus-mediated TRAIL gene Ad/GT-TRAIL ginsenoside Rg3 combination. Cell growth and apoptosis were measured by MTT method and flow cytometry. RESULTS The cell line HCE8693 was either suppressed by a higher concentration (0.01% ,0.017% ,0.025% ,0.05%) of ginsenoside Rg3 or by TRAIL gene in 2000 MOI. The suppression percentages were 8.6%,8.6%,18.7%,21.9% and24.3% respectively, and the apoptotic percentage were 5.4% ,7.6% ,20.3% ,20.9% and 23.2% respectively. Combined with ginsenoside Rg3 , the suppression and the apoptotic percentage reached 17.8% , 25.7% , 37.3% , 46.2% and 18.9% ,20.1% ,46.2% ,56.0% respectively.CONCLUSIONS A higher concentration of ginsenoside Rg3 or TRAIL gene was able to induce apoptosis and suppress the growth of human colon cancer cell line HCE8693. Ginsenoside Rg3 combined with TRAIL, the suppression and apoptosis could be significantly enhanced. Ginsenoside Rg3 inhibits the growth of HCE8693 and induces apoptosis in a dose-dependent manner.